Dermatology and Pregnancy

  • Gilvan Ferreira AlvesEmail author
  • Vanessa Teixeira Zanetti
  • Rômulo Mateus Fonseca Viegas


Cutaneous manifestations during pregnancy can be divided into physiologic and pathologic, resulting from many changes in the mother’s body. They encompass physiologic changes, dermatoses affected by the gestational condition, and dermatoses of the gestational period per se. The names and classification of these dermatoses have gone through many changes over the years, and recently were all simplified and summarized into the pregnancy-specific dermatoses: pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy, and atopic eruption of pregnancy. Pregnancy has a tendency to affect the course of the immunomediated diseases, with improvement in most of the cases, such as psoriasis, and worsening of other diseases, such as pemphigus, dermatopolymyositis, and lupus erythematosus. A watchful diagnosis and patient follow-up are crucial for treatment aimed at the prevention of maternal and fetal complications.


Cholestasis, Intrahepática Dermatitis, Atopic Skin diseases Pregnancy Complications Diagnosis Therapeutics 




Any disease of the skin.


An inflammatory condition of the skin attended with itching and the exudation of serous matter.


The condition of having antigenic similarities such that cells or tissues transplanted from one (the donor) to another (the recipient) are not rejected.

Immune complex

Aggregate of an antigen and its specific antibody.


Technique used in removing surface stains, using abrasive or erosive substances.


  1. 1.
    Alves GF, Nogueira LSC, Varella TCN. Dermatologia e gestação. An Bras Dermatol. 2005;80(2):179–86.CrossRefGoogle Scholar
  2. 2.
    Neves C, Medina JL, Delgado JL. Alterações endócrinas e imuno-modulação na gradidez. Arq Med. 2007;21(5/6):175–82.Google Scholar
  3. 3.
    Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37:429–31.CrossRefPubMedGoogle Scholar
  4. 4.
    Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15:35–43.CrossRefPubMedGoogle Scholar
  5. 5.
    Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol. 1992;31:375–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Kumari R, Jaisankar TJ, Thappa DM. A clinical study of skin changes in pregnancy. Indian J Dermatol Venereol Leprol. 2007;73:141.PubMedGoogle Scholar
  7. 7.
    Zanini M, et al. Dermatoses gestacionais. Med Cutan Iber Lat Am. 2004;32(4):139–50.Google Scholar
  8. 8.
    Wong RC. Physiologic skin changes in pregnancy. J Am Acad Dermatol. 1984;10:929–40.CrossRefPubMedGoogle Scholar
  9. 9.
    Pennoyer JW, Grin CM, Driscoll MS, Dry SM, Walsh SJ, Gelineau JP, et al. Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol. 1997;36:378–82.CrossRefPubMedGoogle Scholar
  10. 10.
    Wong RC, Ellis CN. Physiologic skin changes in pregnancy. Semin Dermatol. 1989;8:7–11.PubMedGoogle Scholar
  11. 11.
    Carneiro SCS, Abulafia LA. Pele na gestação. Ver Bras Reumatol. 2005;45(3):146–52.Google Scholar
  12. 12.
    Holmes RC, Black MM, Dann J, James DC, Bhogal B. A comparative study of toxic erythema of pregnancy and herpes gestationis. Br J Dermatol. 1982;106:499–510.CrossRefPubMedGoogle Scholar
  13. 13.
    Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol. 1983;8:405–12.CrossRefPubMedGoogle Scholar
  14. 14.
    Zoberman E, Farmer ER. Pruritic folliculitis of pregnancy. Arch Dermatol. 1981;117:20–2.CrossRefPubMedGoogle Scholar
  15. 15.
    Shornick JK. Dermatoses of pregnancy. Semin Cutan Med Surg. 1998;17:172–81.CrossRefPubMedGoogle Scholar
  16. 16.
    Ambros-Rudolph CM. Dermatoses of pregnancy – clues to diagnosis, fetal risk and therapy. Ann Dermatol. 2011;23(3):265–75.Google Scholar
  17. 17.
    Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones AS, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnancy patient. J Am Acad Dermatol. 2006;54:395–404.CrossRefPubMedGoogle Scholar
  18. 18.
    Ambros-Rudolph CM. Disorders of pregnancy. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, editors. Braun-Falco’s dermatology. 3rd ed. Heidelberg: Springer Medizin Verlag; 2009. p. 1160–9.CrossRefGoogle Scholar
  19. 19.
    Jones SAV, Black MM. Pregnancy dermatoses. J Am Acad Dermatol. 1999;40:233–41.CrossRefGoogle Scholar
  20. 20.
    Winton GB, Major MC, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol. 1982;6:977–98.CrossRefPubMedGoogle Scholar
  21. 21.
    Holmes RC, Black MM. Herpes gestationis. Dermatol Clin. 1983;1:195–203.CrossRefGoogle Scholar
  22. 22.
    Black MM. New observations on pemphigoid gestationis. Dermatology. 1994;189:50–1.CrossRefPubMedGoogle Scholar
  23. 23.
    Holmes RC, Black MM, James DC. HLA-DR and herpes gestationis. J Invest Dermatol. 1984;83:78–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Kolodny RC. Herpes gestationis. A new assessment of incidence, diagnosis, and fetal prognosis. Am J Obstet Gynecol. 1969;104:39–45.CrossRefPubMedGoogle Scholar
  25. 25.
    Shornick JK. Herpes gestationis. Dermatol Clin. 1993;11:527–33.CrossRefPubMedGoogle Scholar
  26. 26.
    Kroumpouzos G, Cohen LM. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol. 2003;188:1083–92.CrossRefPubMedGoogle Scholar
  27. 27.
    Roger D, Vaillant L, Lorette G, et al. Specific pruritic diseases of pregnancy. Arch Dermatol. 1994;130:734–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Sasseville D, Wilkinson RD, Schnader JY. Dermatoses of pregnancy. Int J Dermatol. 1981;20:223–41.CrossRefPubMedGoogle Scholar
  29. 29.
    Wöhrl S, Geusau A, Karlhofer F, Derfler K, Stingl G, Zillikens D. Pemphigoid gestationis: treatment with immunoapheresis. J Dtsch Dermatol Ges. 2003;1:126–30.CrossRefPubMedGoogle Scholar
  30. 30.
    Bourne G. Toxaemic rash of pregnancy. Proc R Soc Med. 1962;55:462–4.PubMedGoogle Scholar
  31. 31.
    Rudolph CM, Al-Fares S, Vaughan-Jones SA, Müllegger RR, Kerl H, Black MM. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol. 2006;154:54–60.CrossRefPubMedGoogle Scholar
  32. 32.
    Ambros-Rudolph CM, Black MM. Polymorphic eruption of pregnancy. In: Black MM, Ambros-Rudolph CM, Edwards L, Lynch P, editors. Obstetric and gynecologic dermatology. 3rd ed. London: Elsevier Limit; 2008. p. 49–56.CrossRefGoogle Scholar
  33. 33.
    Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999;141:71–81.CrossRefPubMedGoogle Scholar
  34. 34.
    Ahmadi S, Powell F. Pruritic urticarial papules and plaques of pregnancy: current status. Australas J Dermatol. 2005;46:53–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33:1012–21.CrossRefPubMedGoogle Scholar
  36. 36.
    Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin N Am. 1992;21:905–21.Google Scholar
  37. 37.
    Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch Dermatol. 2007;143:757–62.CrossRefPubMedGoogle Scholar
  38. 38.
    Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J Hepatol. 1998;28:91–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Carter J. Serum bile acids in normal pregnancy. Br J Obstet Gynaecol. 1991;98:540–3.CrossRefPubMedGoogle Scholar
  40. 40.
    Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40:467–74.CrossRefPubMedGoogle Scholar
  41. 41.
    Zapata R, Sandoval L, Palma J, Hernández I, Ribalta J, Reyes H, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int. 2005;25:548–54.CrossRefPubMedGoogle Scholar
  42. 42.
    Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology. 2005;129:894–901.CrossRefPubMedGoogle Scholar
  43. 43.
    Reed BR. Dermatologic drugs, pregnancy and lactation. Arch Dermatol. 1997;133:894–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Semkova K, Black MM. Pemphigoid gestacionais: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol. 2009;145:138–44.CrossRefPubMedGoogle Scholar
  45. 45.
    Teixeira V, Coutinho I, Gameiro R, Vieira R, Gonçalo M. Dermatoses específicas da gravidez. Acta Medica Port. 2013;26(5):593–600.Google Scholar
  46. 46.
    Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15:2049–66.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Gilvan Ferreira Alves
    • 1
    • 2
    Email author
  • Vanessa Teixeira Zanetti
    • 3
  • Rômulo Mateus Fonseca Viegas
    • 4
  1. 1.London UniversityLondonUK
  2. 2.Private PracticeBrasíliaBrazil
  3. 3.Hospital Santa Casa de Belo Horizonte – SCBH (MG)Belo HorizonteBrazil
  4. 4.Division of Plastic Surgery, Fhemig (MG)São PauloBrazil

Personalised recommendations